$CNFN
CFN Enterprises Inc. Stock $cnfn

$cnfn Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000143774915015732 Filed on August 13, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$5.466M	$3.906M
YoY Change	39.92%	72.85%
Cost Of Revenue	$1.591M	$1.050M
YoY Change	51.6%	114.22%
Gross Profit	$3.874M	$2.857M
YoY Change	35.63%	61.4%
Gross Profit Margin	70.89%	73.13%
Selling, General & Admin	$2.351M	$1.567M
YoY Change	50.03%	20.56%
% of Gross Profit	60.69%	54.86%
Research & Development	$1.326M	$600.3K
YoY Change	120.97%	39.6%
% of Gross Profit	34.23%	21.01%
Depreciation & Amortization	$84.00K	$45.14K
YoY Change	86.09%	125.69%
% of Gross Profit	2.17%	1.58%
Operating Expenses	$5.593M	$3.568M
YoY Change	56.74%	105.07%
Operating Profit	-$1.718M	-$711.4K
YoY Change	141.55%	-2471.4%
Interest Expense	-$40.00K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$41.51K	$4.932K
YoY Change	-941.57%
Pretax Income	-$1.760M	-$710.0K
YoY Change	147.89%	-3650.0%
Income Tax
% Of Pretax Income
Net Earnings	-$1.760M	-$706.5K
YoY Change	149.11%	-1277.48%
Net Earnings / Revenue	-32.2%	-18.09%
Basic Earnings Per Share	-$0.03	-$0.01
Diluted Earnings Per Share	-$0.03	-$0.01
COMMON SHARES
Basic Shares Outstanding	62.84M	60.03M
Diluted Shares Outstanding	62.84M	60.03M

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$400.0K	$1.420M
YoY Change	-71.83%	56.04%
Cash & Equivalents	$403.7K	$1.421M
Short-Term Investments
Other Short-Term Assets	$400.0K	$40.00K
YoY Change	900.0%	-60.0%
Inventory
Prepaid Expenses
Receivables	$2.287M	$1.590M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.093M	$3.050M
YoY Change	1.41%	62.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.450M	$1.010M
YoY Change	43.59%	1022.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$134.6K	$80.00K
YoY Change	68.21%
Total Long-Term Assets	$1.645M	$1.720M
YoY Change	-4.37%	1811.11%
TOTAL ASSETS
Total Short-Term Assets	$3.093M	$3.050M
Total Long-Term Assets	$1.645M	$1.720M
Total Assets	$4.738M	$4.770M
YoY Change	-0.67%	142.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.690M	$1.690M
YoY Change	0.0%	604.17%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$1.000M
YoY Change		1900.0%
Total Short-Term Liabilities	$1.749M	$2.730M
YoY Change	-35.93%	425.0%
LONG-TERM LIABILITIES
Long-Term Debt	$4.500M	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.500M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.749M	$2.730M
Total Long-Term Liabilities	$4.500M	$0.00
Total Liabilities	$6.249M	$2.730M
YoY Change	128.91%	425.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.36M
YoY Change
Common Stock	$62.84K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.511M	$2.040M
YoY Change
Total Liabilities & Shareholders Equity	$4.738M	$4.770M
YoY Change	-0.67%	142.13%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$1.760M	-$706.5K
YoY Change	149.11%	-1277.48%
Depreciation, Depletion And Amortization	$84.00K	$45.14K
YoY Change	86.09%	125.69%
Cash From Operating Activities	-$1.440M	-$170.0K
YoY Change	747.06%	-180.95%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$150.0K
YoY Change	-46.67%	650.0%
Acquisitions
YoY Change
Other Investing Activities	-$190.0K	-$160.0K
YoY Change	18.75%	-366.67%
Cash From Investing Activities	-$260.0K	-$310.0K
YoY Change	-16.13%	-875.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	600.0K	770.0K
YoY Change	-22.08%	165.52%
NET CHANGE
Cash From Operating Activities	-1.440M	-170.0K
Cash From Investing Activities	-260.0K	-310.0K
Cash From Financing Activities	600.0K	770.0K
Net Change In Cash	-1.100M	290.0K
YoY Change	-479.31%	-46.3%
FREE CASH FLOW
Cash From Operating Activities	-$1.440M	-$170.0K
Capital Expenditures	-$80.00K	-$150.0K
Free Cash Flow	-$1.360M	-$20.00K
YoY Change	6700.0%	-108.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	aclzob	Class Of Warrant Or Right Exercise Of Warrants ClassOfWarrantOrRightExerciseOfWarrants	1632051
	aclzob	Fair Value Of Warrants Issued In Connection With Line Of Credit FairValueOfWarrantsIssuedInConnectionWithLineOfCredit	37289
	aclzob	Fair Value Of Warrants Issued In Connection With Line Of Credit FairValueOfWarrantsIssuedInConnectionWithLineOfCredit	32067
	aclzob	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	626250
	aclzob	Class Of Warrant Or Right Exercise Of Warrants ClassOfWarrantOrRightExerciseOfWarrants	11457
	aclzob	Cashless Exercise Of Options CashlessExerciseOfOptions	21458
	aclzob	Cashless Exercise Of Options CashlessExerciseOfOptions	79158
	aclzob	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	538542
CY2015Q2	aclzob	Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations	62835140
CY2014Q2	aclzob	Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations	60026430
	aclzob	Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations	62833091
	aclzob	Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations	59401930
CY2015Q2	aclzob	Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss	15159042
CY2014Q2	aclzob	Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss	15544549
	aclzob	Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss	17443244
	aclzob	Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss	15822329
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1689693
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1202495
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2286592
	dei	Entity Central Index Key EntityCentralIndexKey	0001352952
	dei	Entity Registrant Name EntityRegistrantName	ACCELERIZE INC.
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62914540
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1749566
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	175278
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109438
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	339132
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	167461
CY2015Q2	us-gaap	Accumulated Amortization Of Noncurrent Deferred Finance Costs AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts	37899
CY2014Q4	us-gaap	Accumulated Amortization Of Noncurrent Deferred Finance Costs AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts	19317
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1322431
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	826802
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8943
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10971
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20791623
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19618153
CY2015Q2	us-gaap	Advertising Expense AdvertisingExpense	83586
CY2014Q2	us-gaap	Advertising Expense AdvertisingExpense	87099
	us-gaap	Advertising Expense AdvertisingExpense	235083
	us-gaap	Advertising Expense AdvertisingExpense	119310
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5364
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	212113
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18583
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3750
CY2015Q2	us-gaap	Assets Assets	4737937
CY2014Q4	us-gaap	Assets Assets	4976393
CY2015Q2	us-gaap	Assets Current AssetsCurrent	3093112
CY2014Q4	us-gaap	Assets Current AssetsCurrent	3084501
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37561
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	870634
CY2014Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	841724
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1130667
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1157315
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	403674
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1421163
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-726993
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	263848
CY2015Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62837351
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62816554
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62837351
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62816554
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	62836
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	62815
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1751349
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-705418
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3352114
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1071702
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. During the six-month period ended June 30, 2015, the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. None of the Company’s customers accounted for more than 10% of its accounts receivable at June 30, 2015 or December 31, 2014.  The Company does not require any collateral from its customers.</div></div></div></div>
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	1591345
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	1049668
	us-gaap	Cost Of Revenue CostOfRevenue	2909111
	us-gaap	Cost Of Revenue CostOfRevenue	1838767
CY2015Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	59957
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	37750
CY2015Q2	us-gaap	Deferred Revenue DeferredRevenue	57134
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	206475
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	57134
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	206475
CY2015Q2	us-gaap	Depreciation Depreciation	83996
CY2014Q2	us-gaap	Depreciation Depreciation	45137
	us-gaap	Depreciation Depreciation	156498
	us-gaap	Depreciation Depreciation	77484
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	791926
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	578278
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2028
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2399
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1676874
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1000000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	703704
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	296296
CY2015Q2	us-gaap	Gross Profit GrossProfit	3874479
CY2014Q2	us-gaap	Gross Profit GrossProfit	2856741
	us-gaap	Gross Profit GrossProfit	7756375
	us-gaap	Gross Profit GrossProfit	5494839
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3354142
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1074101
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	446136
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9160
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	330277
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	525412
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-149341
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-38007
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1576
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	38006
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	196268
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-45314
CY2014Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1069
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2028
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2399
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8571
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1069
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	62893
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2112
	us-gaap	Interest Expense Debt InterestExpenseDebt	108237
	us-gaap	Interest Expense Debt InterestExpenseDebt	5421
	us-gaap	Interest Paid InterestPaid	88300
	us-gaap	Interest Paid InterestPaid
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	21387
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	7044
	us-gaap	Investment Income Interest InvestmentIncomeInterest	54365
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7044
CY2015Q2	us-gaap	Liabilities Liabilities	6249137
CY2014Q4	us-gaap	Liabilities Liabilities	4308970
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4737937
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4976393
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1749137
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1408970
CY2015Q2	us-gaap	Line Of Credit LineOfCredit	4500000
CY2015Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	6000000
CY2014Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3000000
CY2015Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4500000
CY2014Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	2900000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1609586
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1531219
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-483514
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-498103
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1855093
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-771667
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-1759920
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-706487
	us-gaap	Net Income Loss NetIncomeLoss	-3354142
	us-gaap	Net Income Loss NetIncomeLoss	-1074101
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1759920
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-706487
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3354142
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1074101
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41506
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4932
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53872
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1623
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2015Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2014Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	5592893
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	3568160
	us-gaap	Operating Expenses OperatingExpenses	11056645
	us-gaap	Operating Expenses OperatingExpenses	6570563
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115473
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186997
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	368041
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	311106
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	402846
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	204268
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2028
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2399
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8571
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1069
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2028
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2399
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2310
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	40000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1718414
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-711419
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3300270
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1075724
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134564
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	132988
CY2015Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	8571
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19002574
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Reclassification</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The financial statements for the three and six-month periods ended June 30, 2014 have been reclassified to reflect the increase in personnel last year which allowed for more clearly defined roles and allocation of certain unallocated general and administrative expenses to the Company’s functional areas.</div></div></div></div>
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1600000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1000000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9586
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	571219
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-1759920
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-706487
	us-gaap	Profit Loss ProfitLoss	-3354142
	us-gaap	Profit Loss ProfitLoss	-1074101
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2772735
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2251660
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1450304
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1424858
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-206749
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-20628
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1326410
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600259
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2201792
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1177045
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22356716
CY2015Q2	us-gaap	Revenues Revenues	5465824
CY2014Q2	us-gaap	Revenues Revenues	3906409
	us-gaap	Revenues Revenues	10665486
	us-gaap	Revenues Revenues	7333606
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1915053
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1400559
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4048977
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3023008
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2351430
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1567342
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4805876
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2370510
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	22500000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	390000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1017500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.51
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.009
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2015Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	62835140
CY2014Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	60026430
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62833091
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59401930
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	62833091
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	59401930
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62835140
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60026430
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9340
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50390
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1126615
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	287985
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	-1511200
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	667423
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div>
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62835140
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60026430
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62833091
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59401930

Files In Submission

Name	View Source	Status
0001437749-15-015732-index-headers.html	Edgar Link	pending
0001437749-15-015732-index.html	Edgar Link	pending
0001437749-15-015732.txt	Edgar Link	pending
0001437749-15-015732-xbrl.zip	Edgar Link	pending
aclz20150630_10q.htm	Edgar Link	pending
aclzob-20150630.xml	Edgar Link	completed
aclzob-20150630.xsd	Edgar Link	pending
aclzob-20150630_cal.xml	Edgar Link	unprocessable
aclzob-20150630_def.xml	Edgar Link	unprocessable
aclzob-20150630_lab.xml	Edgar Link	unprocessable
aclzob-20150630_pre.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNFN
CFN Enterprises Inc. Stock $cnfn

2015 Q2 Form 10-Q Financial Statement

#000143774915015732 Filed on August 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN CFN Enterprises Inc. Stock $cnfn

2015 Q2 Form 10-Q Financial Statement

#000143774915015732 Filed on August 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN
CFN Enterprises Inc. Stock $cnfn